Akèy › Ensifizyans kadyak › Arizona
Etid klinik pou Ensifizyans kadyak nan Arizona
31 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan Arizona.
Vil nan Arizona
Tèks ofisyèl etid la (Anglè)
ELEVATE-HFpEF Clinical Study
- Banner - University Medical Center Phoenix, Phoenix
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06678841Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Phoenix
- Research Site, Phoenix
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Oct 2, 2026 · NCT06307652A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Banner - University Medical Center Tucson, Tucson
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Oct 1, 2026 · NCT07214376A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- TMC Hlthcr Clin Res Office, Tucson
- Pima Heart and Vascular, Tucson
Ap rekriteFaz 2
Laj 40 a 84 · Tout sèks · Mizajou Sep 30, 2026 · NCT06979362A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Gilbert
- Research Site, Sun City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117BiVACOR® Total Artificial Heart Early Feasibility Study
- Banner - University Medical Center Phoenix, Phoenix
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT06174103Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
- Pima Heart and Vascular Clinical Research, Tucson
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Gilbert
- Research Site, Tempe
- Research Site, Tucson
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- Phoenix, AZ Investigative Site CON-10115, Phoenix
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06024746The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
- CardioVascular Associates of Mesa (CVAM), Mesa
- Honor Health, Scottsdale
Ap rekriteEtid obsèvasyon
Laj 22 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07098858A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Glendale, AZ Investigative Site 10096, Glendale
- Phoenix, AZ Investigative Site 10115, Phoenix
- Scottsdale, AZ Investigative Site 10003, Scottsdale
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Mayo Clinic Phoenix, Phoenix
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07069738AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- University of Arizona Sarver Heart Center, Tucson
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Aug 27, 2026 · NCT06793371Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Banner--University Medical Center Phoenix, Phoenix
- Mayo Clinic - Arizona, Phoenix
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05677100Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Chandler
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Pima Heart and Vascular, Tucson
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Tucson
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Mercy Gilbert Medical Center, Gilbert
- Sun City Clinical Research, Glendale
- Honor Health, Phoenix
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Pima Heart and Vascular, Tucson
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303Assessment of CCM in HF With Higher Ejection Fraction
- CardioVascular Associates of Mesa, Mesa
- Chan Heart Rhythm Institute, Mesa
- Southwest Cardiovascular Associates, Mesa
- ak 4 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05064709A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- Phoenix, AZ Investigative Site FIN-10115, Phoenix
- FIN-10401, Yuma, AZ, Yuma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- St. Joseph's Hospital and Medical Center, Phoenix
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Banner-University Medical Center Phoenix, Phoenix
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
- Peak Heart and Vascular, Avondale
- Banner Medical Center, Mesa
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06641362CCM OPEN HF Registry
- Cardiovascular Associates of Mesa, Mesa
- University of Arizona and Banner University Medical Center Phoenix, Phoenix
- HonorHealth Research Institute, Phoenix
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07112924The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers, Gilbert
- Banner Health - Phoenix, Phoenix
- Tucson Medical Center Health, Tucson
- ak 1 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03142152Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
- Gilbert Cardiology, Gilbert
- Arizona Heart Foundation, Phoenix
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT07403669His-Bundle Corrective Pacing in Heart Failure
- University of Arizona, Phoenix
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT05265520Left vs Left Randomized Clinical Trial
- Mercy Gilbert & Chandler Regional Medical Centers, Gilbert AZ, Gilbert
- University of Arizona College of Medicine- Phoenix, Tucson
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05650658Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- HonorHealth, Scottsdale
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2025 · NCT06964464Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
- Multiple Locations, Phoenix
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2024 · NCT04905160Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.